Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Options Medical Weight Loss vs Regenics

Options Medical Weight Loss
Graded #223

Higher grade

vs+1.5
Regenics
Graded #249

Lower grade

The verdict

Options Medical Weight Loss takes it — 65.5/100 to 64/100, but only just.

Options Medical Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Options Medical Weight Loss offers telehealth medical weight-loss programs built around compounded GLP-1 — semaglutide starting around $239/month and tirzepatide from $299/month, plus NAD+ injections at… Regenics is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
54
54
Dose & formulationEven
77
77
Clinical oversightOptions Medical Weight Loss +7
81
74
Labs & monitoringEven
53
53
FulfillmentOptions Medical Weight Loss +1
67
66
Contract termsEven
55
55
Options Medical Weight Loss · left barRegenics · right bar

The numbers

MetricOptions Medical Weight LossRegenics
WeighScore65.5/10064/100
GradeCC
Scorecard rank#223#249
Semaglutide$199/mo (compounded)$199/mo (starting dose, compounded)
Tirzepatide$399/mo (compounded)$279/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only

Strengths

  • LegitScript certified with clear, upfront program pricing
  • Compounded semaglutide (~$239) and tirzepatide (from $299), plus NAD+
  • Structured metabolic-health program with provider support and accountability
  • HSA/FSA eligible with flexible payment options

Where it loses points

  • Doesn't clearly publish which states its telehealth covers
  • Tirzepatide tiers climb to $339-$399/month
  • More program structure (and cost) than medication-only sellers
  • Compounded GLP-1 only online — no brand-name options noted
Regenics

Graded #249 · C

Strengths

  • Hybrid model — in-office visits near Tarzana, CA plus national telemed
  • Physical address published with a Google Maps link
  • Phone support published — uncommon for DTC-only competitors
  • Office hours clearly stated
  • $139/mo first-month intro is competitive with the low end of the market

Where it loses points

  • 503A pharmacy partner not named
  • LegitScript certification not mentioned
  • Full states-served list not disclosed
  • 503A vs 503B designation not specified
  • FDA compounded-medication disclaimer not visible on the homepage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard